• R Andrew Archbold, Kulasegarum Ranjadayalan, Abdel Suliman, Charles J Knight, Andrew Deaner, and Adam D Timmis.
• Department of Cardiology, Newham University Hospital, London, UK. andrew.archbold@bartsandthelondon.nhs.uk
• Clin Cardiol. 2010 Mar 1; 33 (3): E25-9.

AbstractThrombolytic therapy reduces mortality in patients with acute myocardial infarction (AMI) and left bundle branch block (LBBB). The difficulty in accurately diagnosing AMI in patients with LBBB, however, might result in their undertreatment. Among 3,890 patients hospitalized with chest pain, 241 (6.2%) had LBBB at presentation. The only variable independently associated with AMI among patients with LBBB was in-hospital left ventricular failure (odds ratio [OR]: 4.32, 95% confidence interval [CI]: 1.95-9.57, p < 0.0005). Only 16 (29%) of the LBBB patients with AMI received thrombolytic therapy compared with 583 (78%) of the 747 patients with ST-elevation AMI (p < 0.0005). A further 19 (10%) LBBB patients without AMI also received thrombolysis. Difficulty in making an accurate early diagnosis in patients with LBBB ensures that the majority of those with AMI fail to receive thrombolytic therapy while others without AMI are treated inappropriately. Improved diagnostic and therapeutic strategies are needed for patients with acute coronary syndromes and LBBB.Copyright (c) 2010 Wiley Periodicals, Inc.

18 keywords...

hide…